Drug Reform Unlikely to Affect Small Biotech Companies
June 24, 2021 at 06:00 AM EDT
Investing in healthcare stocks is compelling for many investors because of the defensive qualities of blue chip pharmaceuticals companies and the growth prospects of biotechnology names.